In yesterday’s Wall Street session, Adc Therapeutics SA (NYSE:ADCT) shares traded at $3.13, up 63.02% from the previous session.
ADCT stock price is now 12.80% away from the 50-day moving average and -10.39% away from the 200-day moving average. The market capitalization of the company currently stands at $493.37M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $6, Stephens recently initiated with Overweight rating for Adc Therapeutics SA (NYSE: ADCT). , while ‘Guggenheim’ rates the stock as ‘Buy’
In other news, Redmile Group, LLC, 10% Owner sold 25,352 shares of the company’s stock on Dec 04 ’24. The stock was sold for $52,479 at an average price of $2.07. Upon completion of the transaction, the 10% Owner now directly owns 15,566,731 shares in the company, valued at $48.72 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 01 ’24, 10% Owner Redmile Group, LLC bought 400,000 shares of the business’s stock. A total of $1,124,000 was incurred on buying the stock at an average price of $2.81. This leaves the insider owning 15,669,217 shares of the company worth $49.04 million. A total of 19.50% of the company’s stock is owned by insiders.
During the past 12 months, Adc Therapeutics SA has had a low of $0.94 and a high of $6.04. The fifty day moving average price for ADCT is $2.7748 and a two-hundred day moving average price translates $3.49275 for the stock.
The latest earnings results from Adc Therapeutics SA (NYSE: ADCT) was released for 2024-09-30. The net profit margin was -300.00% and return on equity was -705.53% for ADCT. The company reported revenue of $18.46 million for the quarter, compared to $14.49 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 27.4 percent.
